KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) FCF Margin (2016 - 2025)

Resmed's FCF Margin history spans 17 years, with the latest figure at 21.87% for Q4 2025.

  • For Q4 2025, FCF Margin fell 59.0% year-over-year to 21.87%; the TTM value through Dec 2025 reached 33.19%, up 494.0%, while the annual FY2025 figure was 32.29%, 450.0% up from the prior year.
  • FCF Margin reached 21.87% in Q4 2025 per RMD's latest filing, down from 31.02% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 43.19% in Q1 2025 to a low of 10.29% in Q3 2021.
  • Average FCF Margin over 5 years is 20.66%, with a median of 22.28% recorded in 2024.
  • Peak YoY movement for FCF Margin: crashed -2764bps in 2021, then surged 2160bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 21.17% in 2021, then plummeted by -54bps to 9.8% in 2022, then skyrocketed by 119bps to 21.46% in 2023, then grew by 5bps to 22.46% in 2024, then decreased by -3bps to 21.87% in 2025.
  • Per Business Quant, the three most recent readings for RMD's FCF Margin are 21.87% (Q4 2025), 31.02% (Q3 2025), and 37.7% (Q2 2025).